The Gut Microbiota and Effects on Metabolism

作者: S. Hussey , M. Bergman

DOI: 10.1016/B978-0-12-386456-7.02009-8

关键词:

摘要: The gut microbiota is a large and diverse community of microbes that contribute to human metabolism in two ways: by providing nutrients vitamins essential for mammalian viability promoting maximal extraction calories from dietary nutrients. Long known benefit health, emerging evidence indicates the also contributes disease, specifically diseases with metabolic dysfunction – obesity, insulin resistance, type 2 diabetes mellitus, cardiovascular disease. Putative mechanisms linking obesity its complications include microbial effects on (1) short-chain fatty acid production, (2) lipid storage fat oxidation, (3) conversion choline into methylamines, (4) bile acids, (5) intestinal barrier integrity, (6) inflammatory signaling through pattern recognition receptors. While majority mechanistic studies are confined animal models, including both vivo vitro approaches, recent advances utilizing fecal transplants research offer potential study microbiota-mediated abnormalities man. Deliberate manipulation holds much promise development novel therapeutics interventions modify thus improve health.

参考文章(166)
C Larkin, E Bruckner-Kardoss, A Moriarty, B S Wostmann, Dietary intake, energy metabolism, and excretory losses of adult male germfree Wistar rats Laboratory Animal Science. ,vol. 33, pp. 46- 50 ,(1983)
G. M. Barton, R. Medzhitov, Toll-Like Receptors and Their Ligands Current Topics in Microbiology and Immunology. ,vol. 270, pp. 81- 92 ,(2002) , 10.1007/978-3-642-59430-4_5
Stephen Nussey, Saffron A. Whitehead, Endocrinology: An Integrated Approach ,(2001)
Edy Soffer, Robert J Basseri, Adrienne Youdim, Ruchi Mathur, Benjamin Basseri, Laura Hwang, Kelly Chong, Christopher Chang, Kimberly Low, Mark Pimentel, Intestinal methane production in obese individuals is associated with a higher body mass index. Gastroenterología y Hepatología. ,vol. 8, pp. 22- 28 ,(2012)
Chieh Jason Chou, Mathieu Membrez, Florence Blancher, Gut Decontamination with Norfloxacin and Ampicillin Enhances Insulin Sensitivity in Mice Nestle Nutrition workshop series. Paediatric programme. ,vol. 62, pp. 127- 140 ,(2008) , 10.1159/000146256
Christian J Wiedermann, Stefan Kiechl, Stefan Dunzendorfer, Peter Schratzberger, Georg Egger, Friedrich Oberhollenzer, Johann Willeit, Association of endotoxemia with carotid atherosclerosis and cardiovascular disease Journal of the American College of Cardiology. ,vol. 34, pp. 1975- 1981 ,(1999) , 10.1016/S0735-1097(99)00448-9
Paola Gauffin Cano, Arlette Santacruz, Fernando M. Trejo, Yolanda Sanz, BifidobacteriumCECT 7765 improves metabolic and immunological alterations associated with obesity in high-fat diet-fed mice Obesity. ,vol. 21, pp. 2310- 2321 ,(2013) , 10.1002/OBY.20330
Atul Tiwari, GPR43: an emerging target for the potential treatment of type 2 diabetes, obesity and insulin resistance. Current opinion in investigational drugs. ,vol. 11, pp. 385- 393 ,(2010)
B. S. Wostmann, Intestinal Bile Acids and Cholesterol Absorption in the Germfree Rat The Journal of Nutrition. ,vol. 103, pp. 982- 990 ,(1973) , 10.1093/JN/103.7.982